There is growing evidence suggesting that hyperinsulinemia (high levels of insulin) and insulin resistance, common in type 2 diabetes, are associated with an increased risk of several cancers, such as breast cancer, colorectal cancer, and endometrial cancer. Insulin can act as a growth factor, promoting cell proliferation and inhibiting apoptosis, thus potentially contributing to tumor development.
